Fig. 3: The distributions of risk scores calculated based on various prognostic signatures across the AML cohorts.
From: An immunity and pyroptosis gene-pair signature predicts overall survival in acute myeloid leukemia

A Paired IPRP signature. B Unpaired IPRP signature, C Pyroptosis signature, D IRG signature, E Autophagy signatures, F Hypoxia signature, G CXCR signature, H 24-gene signature, I LSC17 signature, J 7-gene signature, K pLSC6 signature, L PS29MRC signature. The differences between the score distributions across the cohorts were assessed with ANOVA test (not a formal statistical hypothesis testing).